1. Tamoxifen resistance alters sensitivity to 5-fluorouracil in a subset of estrogen receptor-positive breast cancer
   Takayuki Watanabe et al, 2021, PLOS ONE CrossRef
2. Identification of miRNAs as biomarkers for acquired endocrine resistance in breast cancer
   Penn Muluhngwi et al, 2017, Molecular and Cellular Endocrinology CrossRef
3. Tamoxifen resistance: From cell culture experiments towards novel biomarkers
   Norbert Nass et al, 2015, Pathology - Research and Practice CrossRef
4. KLF4 overcomes tamoxifen resistance by suppressing MAPK signaling pathway and predicts good prognosis in breast cancer
   Yunlu Jia et al, 2018, Cellular Signalling CrossRef
5. Combined microRNA and ER expression: a new classifier for familial and sporadic breast cancer patients
   Katia Danza et al, 2014, Journal of Translational Medicine CrossRef
6. Non-Coding RNAs in Breast Cancer: Intracellular and Intercellular Communication
   Carolyn M. Klinge, 2018, Non-Coding RNA CrossRef
7. Recurrence prediction using microRNA expression in hormone receptor positive breast cancer during tamoxifen treatment
   Chungyeul Kim et al, 2018, Biomarkers CrossRef
8. MicroRNA‐335‐5p and ‐3p synergize to inhibit estrogen receptor alpha expression and promote tamoxifen resistance
   Elizabeth C. Martin et al, 2017, FEBS Letters CrossRef
9. Tumor‐associated macrophages secrete CC‐chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer
   Dongbo Li et al, 2020, Cancer Science CrossRef
10. Regulation of tamoxifen sensitivity by the PLAC8/MAPK pathway axis is antagonized by curcumin-induced protein stability change
    Misha Mao et al, 2021, Journal of Molecular Medicine CrossRef
11. HOTAIR Facilitates Endocrine Resistance in Breast Cancer Through ESR1/miR-130b-3p Axis: Comprehensive Analysis of mRNA-miRNA-lncRNA Network
    Mingdi Zhang et al, 2021, International Journal of General Medicine CrossRef
12. Seven In Absentia Homolog 2 (SIAH2) downregulation is associated with tamoxifen resistance in MCF-7 breast cancer cells
    Rodrigo B. Interiano et al, 2014, Journal of Surgical Research CrossRef
13. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer
    Paul Vilquin et al, 2015, Breast Cancer Research CrossRef
14. HMGB1 is a key factor for tamoxifen resistance and has the potential to predict the efficacy of CDK4/6 inhibitors in breast cancer
    Han Zhang et al, 2021, Cancer Science CrossRef